Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-16T04:46:08.669476+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/companies/immix-biopharma-inc.md
Open Markdown

Immix Biopharma, Inc.

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-1
Canonical entityalpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f
Entity typeCompany
Canonical URLhttps://registry.alpha.ac/companies/immix-biopharma-inc
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims14
Claims under review1
Evidence records3
Conflicts0
Conflicts in internal review0
Observed2026-09-16T04:46:08.669476+00:00
Last reviewed2026-09-16T04:46:08.669476+00:00

Identity

  • Legal name: Immix Biopharma, Inc.
  • Display name: Immix Biopharma, Inc.

Leadership

  • Carey Ng, PhD, MBA: Director. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Gabriel Morris, BA: Director. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Helen C. Adams, CPA: Director. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Ilya Rachman, MD, PhD, MBA: Director. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Jane Buchan, PhD: Director. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Jason Hsu, PhD, MS: Director. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Magda Marquet, PhD: Director. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Nancy Chang, PhD: Director. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Yekaterina Chudnovsky, JD: Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:2.
  • Gabriel Morris: Chief Financial Officer and President. Valid from: 2026-03-25. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:3.
  • Ilya Rachman: Chief Executive Officer, Chief Scientific Officer and Chairman of the Board of Directors. Valid from: 2026-03-25. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:3.

Roles

  • PUBLISHED

Governance

  • NOT_ASSERTED

Board committees

  • PUBLISHED

Financials

  • NOT_ASSERTED

Workforce

  • NOT_ASSERTED

Market and index context

  • PUBLISHED

Legal Name

  • Immix Biopharma, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:1.

Headquarters

  • US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

  • Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:1.

Published Fact

  • US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:1.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessPUBLISHED
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernanceNOT_ASSERTED
FinancialsNOT_ASSERTED
WorkforceNOT_ASSERTED
OwnershipNOT_ASSERTED
RatingsNOT_PUBLISHED
Market and index contextPUBLISHED

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations